| Characteristic | Glycaemic control | Morbidity | Severe / serious adverse events | Insulin sensitivity | Health‐related quality of life | Well‐being | Physical function | Cognitive function |
| Ludvik 2002 | Change in fasting blood glucose and HbA1c | ‐ | ND | ND | ‐ | ‐ | ‐ | ‐ |
| Ludvik 2004 | Change in fasting blood glucose and HbA1c | ‐ | ND | ND | ‐ | ‐ | ‐ | ‐ |
| Ludvik 2008 | Changes in HbA1c | ‐ | ND | Oral glucose insulin sensitivity (OGIS), as glucose clearance from oral glucose tolerance test | ‐ | ‐ | ‐ | ‐ |
|
Footnotes "‐" denotes not reported HbA1c: glycosylated haemoglobin A1c; ND: not defined | ||||||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.